CANCER CENTER SUPPORT GRANT

癌症中心支持补助金

• 批准号: 6362618
• 负责人: WILLIAM N. HAIT
• 金额: $ 224.87万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-04-06 至 2004-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6362618
• 关键词: biomedical facility; neoplasm /cancer

The Cancer Institute of New Jersey (CINJ) is a matrix style cancer center under the auspices of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. The Director serves as Associate Dean for Oncology Programs and is responsible for integrated research at the medical school with the Robert Wood Johnson University Hospital, the St. Peter's University Hospital, and several schools and departments of Rutgers University. CINJ was awarded its first P30 Cancer Support Grant (CA72720) on March 1, 1997. CINJ has 124 members, whose peer-reviewed, funded research projects, as defined by the CCSG guidelines, total more than $26.5 million in annual direct costs, over $6 million of which is from the NCI. The research base of CINJ is organized into seven programs: Cancer Pharmacology; Carcinogenesis and Chemoprevention; Molecular Mechanisms of Tumor Growth; Cytokines, Growth Factors, and Signal Transduction: Transcriptional Regulation and Oncogenesis; Clinical Investigations; and Cancer Control. With this application, CINJ has added programmatic strength in Population Science through two programs, Carcinogenesis and Chemoprevention, and Cancer Control. This application requests support for the following: Senior Leadership; Major Program Leaders; Planning and Evaluation; Developmental Funds; Administration; Clinical Protocol Scientific Review and Monitoring; and Protocol Specific Research. In addition, we are requesting funds for the following shared resources of CINJ: Analytical Cytometry; DNA Synthesis and Sequencing; Laboratory Support Services; Immunohistochemistry; Tissue Retrieval Service; Biometrics; Research Pharmacy; and Clinical Research Office.

新泽西癌症研究所（CINJ）是一个矩阵式癌症中心，由新泽西大学医学和牙科-罗伯特伍德约翰逊医学院赞助。主任担任肿瘤学项目副院长，负责与罗伯特·伍德约翰逊大学医院、圣彼得大学医院以及罗格斯大学的几个学院和系进行综合研究。CINJ于1997年3月1日获得了第一笔P30癌症支持补助金（CA 72720）。CINJ有124个成员，其同行评审，资助的研究项目，根据CCSG准则的定义，每年的直接费用总额超过2650万美元，其中超过600万美元来自NCI。CINJ的研究基地分为七个项目：癌症药理学;致癌和化学预防;肿瘤生长的分子机制;细胞因子，生长因子和信号转导：转录调控和肿瘤发生;临床研究;和癌症控制。有了这个应用程序，CINJ通过两个程序增加了人口科学的程序强度，致癌和化学预防，以及癌症控制。此应用程序要求支持以下内容：高级领导;主要项目负责人;规划和评估;发展基金;管理;临床方案科学审查和监测;以及方案特定研究。此外，我们正在为CINJ的以下共享资源申请资金：分析细胞计数; DNA合成和测序;实验室支持服务;免疫组织化学;组织检索服务;生物统计学;研究药房;和临床研究办公室。